Unique ID issued by UMIN | UMIN000014675 |
---|---|
Receipt number | R000017067 |
Scientific Title | Assessment of the prognostic significance of the leg positive pressure stress echocardiography for patients with chronic heart failure |
Date of disclosure of the study information | 2014/09/01 |
Last modified on | 2018/07/31 16:32:35 |
Assessment of the prognostic significance of the leg positive pressure stress echocardiography for patients with chronic heart failure
Prognostic assessment using leg positive pressure stress echocardiography
Assessment of the prognostic significance of the leg positive pressure stress echocardiography for patients with chronic heart failure
Prognostic assessment using leg positive pressure stress echocardiography
Japan |
Patients with chronic heart failure
Cardiology |
Others
NO
The aim of this study is to assess the left ventricular preload reserve using leg positive pressure stress echocardiography, and to assess the relationship between left ventricular functional reserve and the patient's prognosis.
Efficacy
Combined endpoint of admission due to heart failure, death from heart failure, and sudden cardiac death
1) Change in NYHA functional class from baseline
2) Changes in left ventricular ejection fraction, left ventricular end-diastolic, and end-systolic volume from baseline
3) Changes in right ventricular and left atrial function from baseline using speckle-tracking echocardiography
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Device,equipment |
Leg positive pressure stress echocardiography
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1 Patients between 20 and 80 years old
2 Out patients and inpatients with chronic heart failure
3Patients with hemodynamically stable condition with standard heart failure treatment including beta blocker, ACE inhibitor, ARB, and diuretics.
4 Patients who can tolerate 5 minutes of leg positive pressure stress echocardiography.
5 Patients with symptom of heart failure, or those with previous admission due to heart failure.
6 Patients with written informed consent.
7 Patients whose medication will not significantly change during 2 years study period.
1) Patients with significant hypotension (<90/50mmHg) or uncontrolled hypertension (>160/90mmHg).
2) Patients with acute illness within 3 months.
3) Patients with life-threatening ventricular arrhythmia.
4) Patients with NYHA 4 heart failure.
5) Patients with severe hepatic diseases including fulminant hepatitis, liver cirrhosis, or hepatic tumor.
6) Patients with severe renal diseased or those with hemodialysis.
7) Patients who experienced malignancy within 5 years.
8) Pregnant women.
9) Patients with venous thrombosis or the history of venous thrombosis.
70
1st name | |
Middle name | |
Last name | Kensuke Matsumoto |
Kobe university hospital
Division of cardiology
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
078-382-5846
kenmatsu@med.kobe-u.ac.jp
1st name | |
Middle name | |
Last name | Kensuke Matsumoto |
Kobe university hospital
Division of cardiology
7-5-2, Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
078-382-5846
kenmatsu@med.kobe-u.ac.jp
Division of cardiology, Kobe university hospital
self funding
Self funding
NO
2014 | Year | 09 | Month | 01 | Day |
Published
Completed
2014 | Year | 07 | Month | 26 | Day |
2014 | Year | 09 | Month | 01 | Day |
2014 | Year | 07 | Month | 28 | Day |
2018 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017067